Pharmaceuticals & Biotechnology

Jen Fonner Fitchen

Jen is a highly regarded dealmaker, strategist and corporate advisor who has led hundreds of industry-changing transactions involving more than $230 billion in value for companies ranging from groundbreaking start-ups to global Fortune 500 companies. As a 30-year veteran of Silicon Valley, boards of directors and executive teams rely on … Read more

Sally A. Thurston

Sally A. Thurston is a strategic business partner who recently retired from global law firm Skadden Arps. Ms. Thurston was a results-oriented tax advisor to Fortune 500 companies on multi-billion dollar transactions for 35 years and is an expert on combinations between US and foreign multinationals, cross-border structures and post-acquisition … Read more

Mary Smith

Mary Smith is an independent board member, former CEO of a $6 billion national healthcare organization and C-suite executive with 25+ years of business experience. Mary currently serves on the board of PTC Therapeutics, Inc. (NASDAQ: PTCT), a global biopharmaceutical company focused on the discovery, development and commercialization of … Read more

Lisa J. Brown

Lisa J. Brown is an accomplished global C-suite executive and corporate Board member with diverse experience in a variety of industries including, automotive, transportation technology, consumer healthcare and pharma, medical devices, agrisciences and chemicals, industrial minerals, mining, and industrial manufacturing.

Since August 2020, Ms. Brown serves on the Board of … Read more

Mary Kate Wold

Mary Kate Wold has held leadership positions in the pharmaceutical and life sciences, financial services, legal, and government sectors, including serving as a board director of numerous organizations. She is currently the CEO and a board member of the Church Pension Group (CPG), a pension and financial services company that … Read more

Rebecca Wing

Rebecca Wing is an experienced General Counsel and interim CEO of a $500,000,000 financial services conglomerate. Ms. Wing has over 25 years of experience in advising companies and has extensive crisis management skills. She is also a corporate board director (since 2005) for Sleeping Bear Inc., a privately held manufacturer.… Read more

Linda A. Willett

Linda A. Willett is Executive Vice President, General Counsel and Secretary for Horizon Blue Cross Blue Shield, the largest health insurance company in New Jersey with almost $12B in revenue in 2020. She works with the Company’s CEO and management team to set strategy and drive business outcomes including transforming … Read more

The Hon. Lynn Schenk

Having decades of experience as a public company board member of Fortune 500 and smaller companies, and  having served at the highest levels of State and Federal government, my objective is to leverage that professional and life experience by adding value to private or public companies, including portfolio companies of … Read more

Catherine Sazdanoff

Catherine is a board member and consultant with extensive global healthcare experience. She is an independent director of the Board of Meridian Bioscience, Inc. (NASDAQ: VIVO) and of Vascugen, Inc. (privately held), and formerly of InMed, Inc. (NASDAQ: INM). Catherine is President/ CEO of Sazdanoff Consulting LLC and serves as … Read more

Karen Popp

KAREN A. POPP is a partner and Global Co-Chair of the White Collar and Compliance Practice at Sidley Austin LLP, where she leads a group of over 175 attorneys.  Karen has 25 years of experience representing corporations, Boards of Directors and members of the C-Suites, from a diverse range of … Read more